Utama › Dermatitis Atopik (Eksim) › California

Kajian klinikal Dermatitis Atopik (Eksim) di California

30 kajian untuk Dermatitis Atopik (Eksim) sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

First OC Dermatology, Irvine

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan

Umur 18 hingga 72 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06808477

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

Kern Research, Inc.- Site Number : 8400047, Bakersfield
Center for Dermatology Clinical Research- Site Number : 8400014, Fremont
Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
dan 4 lagi

Mengambil pesertaKajian pemerhatian

Umur 12 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Fountain Valley
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Sacramento
dan 2 lagi

Mengambil pesertaFasa 2

Umur 18 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Beverly Hills
Enveda Investigative Site, Fremont
Enveda Investigative Site, San Diego
dan 3 lagi

Mengambil pesertaFasa 2

Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07298395

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis

Alliance Clinical West Hills (Focus Clinical Research), West Hills

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan

Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07527923

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
University of California, San Diego/ Rady Children's Hospital - San Diego, San Diego

Mengambil pesertaFasa 3

Umur 2 hingga 11 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06807281

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Marvel Clinical Research, Huntington Beach
Metropolis Dermatology - DTLA, Los Angeles
Northridge Clinical Trials, Northridge
dan 1 lagi

Mengambil pesertaFasa 2

Umur 18 hingga 64 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07216027

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Fountain Valley
Investigational Site, Los Angeles

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07003425

The Impact of Dietary Salt on the Severity of Eczema

San Francisco VA Medical Center, San Francisco
UCSF Mt Zion Campus, San Francisco

Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan

Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07447063

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

UCSF Mt Zion Campus, San Francisco
San Francisco VA Medical Center, San Francisco

Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan

Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07487831

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

UCLA Division of Dermatology, Los Angeles
Dermatology Research Associate, Los Angeles

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07223697

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Northridge Clinical Trials, Northridge

Mengambil pesertaFasa 3

Umur 12 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07765888

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Marvel Research, LLC, Huntington Beach
Metropolis Dermatology, Los Angeles
Dermatology Research Associates, Los Angeles
dan 4 lagi

Mengambil pesertaFasa 2

Umur 18 hingga 65 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07599813

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Allergy and Asthma Medical Group and Research Center, San Diego

Mengambil pesertaKajian pemerhatian

Umur 12 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06899204

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Integrative Skin Science and Research, Sacramento

Mengambil pesertaFasa 4

Umur 12 ke atas · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT07560618

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 1, Lancaster
Inmagene Site 23, Los Angeles

Mengambil pesertaFasa 2

Umur 18 hingga 74 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT07037901

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Encinitas
Enveda Investigative Site, Los Angeles
Enveda Investigative Site, Northridge

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07643766

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Stanford University School of Medicine /ID# 269622, Palo Alto
Integrative Skin Science and Research /ID# 265108, Sacramento

Mengambil pesertaFasa 3

Umur 2 hingga 11 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT06461897

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Anaheim Clinical Trials, LLC, Anaheim
TCR Medical Corporation, San Diego

Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan

Umur 18 hingga 70 · Semua jantina · Dikemas kini 22 Jul 2026 · NCT06564389

Sodium in the Skin and Atopic Dermatitis

San Francisco VA Medical Center, San Francisco
UCSF Mt Zion Campus, San Francisco

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 50 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT06998446

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Leo Pharma Investigational site, Palo Alto
Leo Pharma Investigational site, Sacramento
Leo Pharma Investigational site, San Diego

Mengambil pesertaFasa 3

6 Months – 11 Years · Semua jantina · Dikemas kini 7 Jul 2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Exalt Clinical Research /ID# 281611, Chula Vista
Private Practice - Dr. Tooraj Raoof /ID# 263849, Encino
First OC Dermatology /ID# 263349, Fountain Valley
dan 8 lagi

Mengambil pesertaFasa 3

Umur 18 hingga 63 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06389136

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

University of California, San Diego: Dermatology Clinical Trials Unit, San Diego

Mengambil pesertaFasa 1

Umur 6 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06504160

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

First OC Dermatology, Fountain Valley
Center for Dermatology Clinical Research, Inc., Fremont
California Allergy and Asthma Medical Group, Los Angeles
dan 1 lagi

Mengambil pesertaFasa 2

Umur 18 hingga 65 · Semua jantina · Dikemas kini 15 Jun 2026 · NCT06397911

Molecular Signatures of Cutaneous Dupilumab Response

University of California, San Francisco, San Francisco

Mengambil pesertaFasa 4

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Jun 2026 · NCT05858619

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Marvel Clinical Research, Huntington Beach
California Allergy and Asthma Medical Group, Los Angeles
University Dermatology Trials, INC., Newport Beach
dan 4 lagi

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Mei 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site - 7074, Corona
Galderma Investigational Site 8636, Fountain Valley
Galderma Investigational Site 8224, Fremont
dan 4 lagi

Mengambil pesertaKajian pemerhatian

Umur 12 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT06988605

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Corvus Clinical Trials, South San Francisco

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mac 2026 · NCT07441395

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

University of California San Diego (UCSD), La Jolla

Mengambil pesertaKajian pemerhatian

Semua umur · Wanita · Dikemas kini 28 Jan 2025 · NCT05938478

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Physioseq, LLC /ID# 267266, Sacramento

Mengambil pesertaFasa 2

Umur 18 hingga 75 · Semua jantina · Dikemas kini 24 Jan 2025 · NCT06524635

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.